A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- Jonsson Comprehensive Cancer Center
- Study ID
- NCT06568016
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Accepted
Interventions
- Best Practice — OTHERReceive clinical care consistent with current practice
- Communication Intervention — OTHERReceive standardized communication from FIT QI champion
- Communication Intervention — OTHERReceive coordination from GI liaisons
- Coordination — OTHERReceive enhanced GI care coordination
- Educational Intervention — OTHERWatch pre-colonoscopy educational video
- Electronic Health Record Review — OTHERUndergo FIT result review by Primary Care FIT Tracker
- Electronic Health Record Review — OTHERAncillary studies
- Informational Intervention — OTHERUndergo generation and review of GI FIT Tracker report
- Informational Intervention — OTHERReceive informational sheet
- Interview — OTHERAncillary studies
- Patient Navigation — BEHAVIORALReceive navigation from GI liaisons
- Referral — OTHERReceive referral
- Referral — OTHERReceive referral per standardized template
- Text Message-Based Navigation Intervention — OTHERReceive follow-up text message
Study Details
This clinical trial evaluates a clinic-wide intervention called Primary Care-Gastrointestinal (GI) Connect for improving follow-up colonoscopy rates in patients at a Federally Qualified Health Center (FQHC) who have an abnormal fecal immunochemical test (FIT) result. Colorectal cancer screening reduces colorectal cancer incidence and mortality but is underutilized.The most accessible, feasible, and common colorectal cancer screening modality for average-risk individuals in low resource settings such as FQHCs is the stool-based FIT. However, the benefit of FIT screening on colorectal cancer risk is realized only if individuals with abnormal FIT results undergo timely follow-up colonoscopy. Follow-up colonoscopy rates are low and there are many barriers to follow-up colonoscopy in safety net settings such as FQHCs. Effective interventions that are multi-component and improve care coordination are needed to improve abnormal FIT follow-up rates in FQHCs. The Primary Care-GI Connect intervention includes components that enhance care coordination, standardize the referral process, and engage both primary care and specialist physicians. This clinic-wide intervention may improve rates of follow-up colonoscopy after abnormal FIT results in patients seen at FQHCs.
Key Dates
- Start date
- Apr 22, 2025
- Status verified
- Feb 2026
- Primary completion
- Feb 28, 2029
- Completion
- Aug 31, 2029
Study Design
- Enrollment
- 1,500 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Active Comparator: Arm I (usual care)Patients receive clinical care consistent with current practice at NEVHC. Patients have their EHRs reviewed monthly by the Primary Care FIT Tracker for abnormal FIT results and patients with abnormal FIT results receive standardized communication from FIT QI champions about their results and receive a referral to gastroenterology.
- Experimental: Arm II (Usual care + Primary Care - GI Connect)Patients receive clinical care consistent with current practice at NEVHC as described in Arm I. Patients also receive enhanced GI care coordination from GI liaisons, who generate GI FIT Tracker reports and use the GI FIT Tracker reports to follow patients with abnormal FIT results. Patients receive navigation services including contact from GI liaisons about making a GI appointment and enhanced communication between GI specialists and the NEVHC. Patients receive referral to gastroenterology following a standardized referral template and receive colonoscopy education including an informational sheet at the time of referral and a 20-minute pre-colonoscopy educational video. Patients receive a text message at the time of colonoscopy referral emphasizing the importance of colonoscopy after abnormal FIT result.
Primary Outcome Measure
Follow-up colonoscopy rates [ Time Frame: At 6 months ]
Central Contacts
- Jessica Tuan310-825-3181
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UCLA / Jonsson Comprehensive Cancer Center | Los Angeles | California | 90095 | Folasade P. May (PRINCIPAL_INVESTIGATOR) |
| University of California at Los Angeles | Los Angeles | California | 90095-1406 | Folasade P May, MD, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Los Angeles, CA
Related Studies
- Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsPHASE1/PHASE2 · Recruiting · Children's Oncology Group · Birmingham, Alabama
- Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome PatientsRecruiting · Mayo Clinic · Scottsdale, Arizona
- A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H MutationPHASE1 · Recruiting · AstraZeneca · Gilbert, Arizona
- Confronting Cancer as a CommunityRecruiting · University of Southern California · Los Angeles, California